Adverse reactions following intramuscular (IM) injection have included anxiety, mild transient diarrhea, ataxia, nervousness, pruritus, transitory exanthema, and a feeling of swelling of the entire body
Beyond adipose tissue, AOD-9604 has been evaluated in cartilage research
"The FDA's position on AOD-9604 reflects a broader regulatory reckoning with unapproved peptides that entered clinical use without adequate evidence," noted the Endocrine Society's 2024 statement on compounded hormones and peptides
Metabolic Pharmaceuticals Ltd, a Melbourne-based biotech company, licensed the compound and advanced it into human trials
For background on the copper tripeptide itself, Wikipedias GHK-Cu overview provides foundational context
Table of Contents: What is a Vitamin B12 + MIC injection, and how does it work